Analytics
The AI model still has a modest prediction accuracy and is slated for a wider clinical trial soon.
It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets.
This comes after it launched its CDI tool called DxPrime in June.
A review of studies published in npj Digital Medicine found diagnostic and triage accuracy varied but was generally low, raising concerns about using symptom checkers as patient-facing tools.
HIMSS22
Technology can offer insights to users in clear and concise ways, according to Brian Robertson, VisiQuate's founder and CEO.
According to the World Health Organization, breast cancer survival rates vary significantly between different countries.
Insurance navigator Fair Square Medicare raises $15 million, AI-enabled prostate cancer care startup Avenda Health scores $10 million, and oncology clinical trial startup Trial Library emerges from stealth with $5 million.
Dozee's sensor-based technology uses AI to track vital parameters.
Also: Decentralized clinical trial startup Curebase names vice president of clinical operations, and digital opioid use disorder-treatment company Ophelia hires a chief technology officer.
Formerly known as IDx, the company received FDA De Novo clearance in 2018 for its IDx-DR system used to detect diabetic retinopathy.